Respiratory virus season has arrived, and hopefully you’re up to date on vaccinations that can help prevent infectious ...

A new study shows that the addition of respiratory syncytial virus (RSV) to Minnesota’s viral genomic surveillance program ...

There’s been an uptick in viral infections in the post-pandemic period, but that isn’t necessarily a bad thing.View on ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

RSV vaccination was associated with decreased risks for infection and hospitalization, although the decrease was not statistically significant.

What is this silent virus that endangers Filipino Seniors with comorbidities? Respiratory Syncytial Virus (RSV) is not just another cold or flu—it is potentially life- threatening for ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...

(Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory ...